{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "21677266",
  "DateCompleted": {
    "Year": "2011",
    "Month": "10",
    "Day": "24"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "09",
    "Day": "30"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2011",
        "Month": "06",
        "Day": "15"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1152/ajpregu.00136.2011"
    ],
    "Journal": {
      "ISSN": "1522-1490",
      "JournalIssue": {
        "Volume": "301",
        "Issue": "3",
        "PubDate": {
          "Year": "2011",
          "Month": "Sep"
        }
      },
      "Title": "American journal of physiology. Regulatory, integrative and comparative physiology",
      "ISOAbbreviation": "Am J Physiol Regul Integr Comp Physiol"
    },
    "ArticleTitle": "Brain IL-6- and PG-dependent actions of IL-1\u03b2 and lipopolysaccharide in avian fever.",
    "Pagination": {
      "StartPage": "R791",
      "EndPage": "R800",
      "MedlinePgn": "R791-800"
    },
    "Abstract": {
      "AbstractText": [
        "There is no persuasive evidence of a correlation between proinflammatory cytokines and avian fever. In this study, for the first time, we use avian cytokines to investigate a role for proinflammatory cytokines in the central component of avian fever. IL-1\u03b2 and IL-6 injected intracerebroventricularly into Pekin ducks (n = 8) initiated robust fevers of equal magnitude and duration, although there was a significant difference in the latency to a febrile response. In addition, the IL-1\u03b2-induced fever could be abolished with an intracerebroventricular injection of antibodies to avian IL-6 or an oral administration of a PG synthesis inhibitor. Our findings indicate the following sequence of events within the central component of the avian febrile mechanism: IL-1\u03b2 gives rise to bioactive IL-6, which stimulates an accelerated synthesis of PGs, and these PGs then adjust the sensitivity of warm-sensitive neurons in the avian brain stem to mediate fever. Yet PGE\u2082 was not upregulated in the cerebrospinal fluid of ducks made febrile with LPS. We conclude that IL-1\u03b2 and IL-6 may well mediate fever by instigating an accelerated synthesis of brain-derived PG, of a class other than PGE\u2082, or that IL-6 serves as one of the terminal mediators of the avian febrile response."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "School of Physiology, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa. manette.marais@wits.ac.za"
          }
        ],
        "LastName": "Marais",
        "ForeName": "Manette",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Maloney",
        "ForeName": "Shane K",
        "Initials": "SK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gray",
        "ForeName": "David A",
        "Initials": "DA"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Am J Physiol Regul Integr Comp Physiol",
    "NlmUniqueID": "100901230",
    "ISSNLinking": "0363-6119"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Cyclooxygenase Inhibitors"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Inflammation Mediators"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Interleukin-1beta"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Interleukin-6"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Lipopolysaccharides"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Prostaglandins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Recombinant Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "lipopolysaccharide, Escherichia coli O111 B4"
    },
    {
      "RegistryNumber": "144O8QL0L1",
      "NameOfSubstance": "Diclofenac"
    },
    {
      "RegistryNumber": "EC 1.14.99.1",
      "NameOfSubstance": "Prostaglandin-Endoperoxide Synthases"
    },
    {
      "RegistryNumber": "K7Q1JQR04M",
      "NameOfSubstance": "Dinoprostone"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Analysis of Variance"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Antibodies"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Body Temperature Regulation"
    },
    {
      "QualifierName": [
        "immunology",
        "physiopathology"
      ],
      "DescriptorName": "Brain"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Cyclooxygenase Inhibitors"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Diclofenac"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Dinoprostone"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Ducks"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "chemically induced",
        "drug therapy",
        "immunology",
        "physiopathology",
        "veterinary"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Inflammation Mediators"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Injections, Intraventricular"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "metabolism"
      ],
      "DescriptorName": "Interleukin-1beta"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "immunology",
        "metabolism"
      ],
      "DescriptorName": "Interleukin-6"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Lipopolysaccharides"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "chemically induced",
        "drug therapy",
        "immunology",
        "physiopathology"
      ],
      "DescriptorName": "Poultry Diseases"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Prostaglandin-Endoperoxide Synthases"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Prostaglandins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Reaction Time"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Recombinant Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    }
  ]
}